Mometasone Furoate Market size is poised to reach USD 3 billion by the end of 2036, growing at a CAGR of 7% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of mometasone furoate was valued at USD 1 Billion. The market is booming as a result of the rising uncontrolled asthmatic conditions, which affect both children and adults. According to a report by CDC, about 44% of children, and 60% of adults have uncontrolled asthma.
Additionally, there is a rising awareness and focus on skincare and overall well-being as people become more conscious of taking care of their skin and seeking professional advice when needed. This has surpassed the demand for dermatological treatments like mometasone. Also, the expansion of the aging population worldwide is contributing to the growth of the sector.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
7% |
|
Base Year Market Size (2023) |
USD 1 Billion |
|
Forecast Year Market Size (2036) |
USD 3 Billion |
|
Regional Scope |
|
Route of administration (Topical, Nasal, Oral)
In mometasone furoate market, topical segment is poised to account for around 42% share by 2036. The reason behind this lucrative growth is impelled by the surge in the growth of skin conditions like eczema, psoriasis, and dermatitis worldwide. According to a report, about 223 million people worldwide, including 43 million children and young adults, suffered from atopic dermatitis in 2022. Mometasone, in the form of creams, ointments, and lotions, has shown great efficacy in managing these conditions, which leads to its popularity among healthcare professionals and patients.
In addition, advancements in formulation technology have improved the delivery and absorption of mometasone through the skin, enhancing its efficacy. Therefore, these innovations have led to the expansion of the topical segment.
Indication (Allergic Rhinitis, Inflammatory Skin Disorders, Asthma)
The allergic rhinitis segment in mometasone furoate market is set to garner a notable share. It is likely to remain the second largest segment, led by the substantial growth in quicker and higher-quality diagnostic techniques. In addition, the enormous financial burden on society due to disability and early death raises costs for prescription drugs, direct health care, and indirect costs associated with lost productivity.
Treatment for allergic asthma is often required in conjunction with perennial allergic rhinitis. The market size expansion for treatments for allergic rhinitis is also being impacted by this illness worldwide. Moreover, mometasone nasal spray is frequently recommended to help reduce allergic rhinitis symptoms. The expansion of this market size can be attributed to mometasone's efficacy in treating allergic rhinitis.
Our in-depth analysis of the global market includes the following segments:
|
Route of administration |
|
|
Indication |
|
|
Dosage form |
|
|
Distribution channel |
|
North American Market Statistics
By 2036, North American region is expected to capture over 47% mometasone furoate market share. The landscape growth in the region is expected to grow, credited to the surge in the number of awareness campaigns regarding psoriasis and the high prevalence of skin conditions like eczema in the region. According to a report, in North America, 7.5 million individuals suffer from psoriasis every year.
In addition, there has been a surge for skincare and dermatological health, coupled with increasing demand for products like mometasone, as new and improved mometasone formulations have also been made, which will further drive the industrial growth rate, hence augmenting the mometasone furoate market revenue share.
European Market Analysis
The European region will also encounter a huge influence on the mometasone furoate market size expansion in the coming years and will account for the second position owing to the gain in approvals for mometasone spray, coupled with the aging population in many European countries and the increasing need for such products.
Moreover, the presence of e-commerce and online pharmacies has made it easier for people to access and purchase more mometasone-furoate products. In addition, the increasing investments in healthcare industries and the availability of advanced medical facilities in Europe have also supported the growth of the mometasone furoate market.
Author Credits: Smruti Ranjan, Rajrani Baghel
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?